Pike, 1992 Sep, J Clin Oncol, 10, 1503, 10.1200/JCO.1992.10.9.1503
Pourrat, 2004 Apr, Pharm World Sci, 26, 64, 10.1023/B:PHAR.0000018602.02535.70
Rosenberg, 1965 Feb 13, Nature, 205, 698, 10.1038/205698a0
Zwelling, 1979 Feb, Cancer Res, 39, 365
Pinto, 1985, Biochim Biophys Acta, 780, 167
Eastman, 1986 Jul 1, Biochemistry, 25, 3912, 10.1021/bi00361a026
Corden, 1985, Cancer Chemother Pharmacol, 14, 38, 10.1007/BF00552723
Jacobs, 1980, Cancer Treat Rep, 64, 1223
Casper, 1979 Nov-Dec, Cancer Treat Rep, 63, 2023
Belt, 1979 Sep-Oct, Cancer Treat Rep, 63, 1515
Himmelstein, 1981 May, Clin Pharmacol Ther, 29, 658, 10.1038/clpt.1981.91
Schiller, 1989 May, Am J Med, 86, 624, 10.1016/0002-9343(89)90402-6
Weiner, 1983 Oct, Fed Proc, 42, 2974
Bruckner, 1981 Aug, Gynecol Oncol, 12, 64, 10.1016/0090-8258(81)90095-0
Ozols, 1984 Jan, Ann Intern Med, 100, 19, 10.7326/0003-4819-100-1-19
Ozols, 1985 Sep, J Clin Oncol, 3, 1246, 10.1200/JCO.1985.3.9.1246
Rossof, 1972 Dec, Cancer, 30, 1451, 10.1002/1097-0142(197212)30:6<1451::AID-CNCR2820300606>3.0.CO;2-Q
Gandara, 1986 Jun, Cancer Treat Rep, 70, 820
van Rijswijk, 1997 Dec, Ann Oncol, 8, 1235, 10.1023/A:1008296202198
Brivet, 1986, Cancer Chemother Pharmacol, 18, 183, 10.1007/BF00262294
Chu, 1993 Dec 15, Cancer, 72, 3707, 10.1002/1097-0142(19931215)72:12<3707::AID-CNCR2820721224>3.0.CO;2-U
Lagrange, 1994, Eur J Cancer, 30, 2057, 10.1016/0959-8049(94)00332-Y
Jung, 1995 Jul, Korean J Intern Med, 10, 150, 10.3904/kjim.1995.10.2.150
Choi, 2002 Feb, Yonsei Med J, 43, 128, 10.3349/ymj.2002.43.1.128
Erdlenbruch, 2002 May, Med Pediatr Oncol, 38, 349, 10.1002/mpo.1343
Katz, 2003 Jun, J Neuroophthalmol, 23, 132, 10.1097/00041327-200306000-00005
Haupt, 1989 Mar-Apr, Anticancer Res, 9, 427
Sheikh-Hamad, 1997 Oct, J Am Soc Nephrol, 8, 1640, 10.1681/ASN.V8101640
Charlier, 2004 Mar, J Anal Toxicol, 28, 138, 10.1093/jat/28.2.138
McKeage, 1995 Oct, Drug Saf, 13, 228, 10.2165/00002018-199513040-00003
Kris, 1985 Oct, J Clin Oncol, 3, 1379, 10.1200/JCO.1985.3.10.1379
Fassoulaki, 1989 Nov, J R Soc Med, 82, 689, 10.1177/014107688908201123
Skinner, 1995 Jul, Curr Opin Oncol, 7, 310, 10.1097/00001622-199507000-00003
Dentino, 1978 Apr, Cancer, 41, 1274, 10.1002/1097-0142(197804)41:4<1274::AID-CNCR2820410410>3.0.CO;2-F
Gonzales-Vitale, 1977 Apr, Cancer, 39, 1362, 10.1002/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO;2-N
Blachley, 1981 Nov, Ann Intern Med, 95, 628, 10.7326/0003-4819-95-5-628
Schilsky, 1979 Jun, Ann Intern Med, 90, 929, 10.7326/0003-4819-90-6-929
Winkler, 1979 Sep, Ann Intern Med, 91, 502, 10.7326/0003-4819-91-3-502_2
Willox, 1986 Jul, Br J Cancer, 54, 19, 10.1038/bjc.1986.147
Lajer, 1999 Feb, Cancer Treat Rev, 25, 47, 10.1053/ctrv.1999.0097
Stuart-Harris, 1980 Dec 13, Lancet, 2, 1303, 10.1016/S0140-6736(80)92367-3
Hutchison, 1988 Jan, Ann Intern Med, 108, 21, 10.7326/0003-4819-108-1-21
Mariette, 1988 May, Ann Intern Med, 108, 770, 10.7326/0003-4819-108-5-770_2
Stadnicki, 1975 May-Jun, Cancer Chemother Rep, 59, 467
Kohn, 1988 Aug, Laryngoscope, 98, 865, 10.1288/00005537-198808000-00015
Marmor, 1993, Doc Ophthalmol, 84, 237, 10.1007/BF01203656
Panici, 1987 Jun, Cancer Treat Rep, 71, 669
Cohen, 1983 Jun, J Clin Oncol, 1, 392, 10.1200/JCO.1983.1.6.392
Hitchins, 1988 Feb, Aust N Z J Med, 18, 67, 10.1111/j.1445-5994.1988.tb02244.x
Steeghs, 2003 Jul, Anticancer Drugs, 14, 443, 10.1097/00001813-200307000-00009
Berman, 1980 Feb 15, Cancer, 45, 764, 10.1002/1097-0142(19800215)45:4<764::AID-CNCR2820450425>3.0.CO;2-G
Mead, 1982 Sep, Cancer Treat Rep, 66, 1719
Philip, 1991 Feb 16, BMJ, 302, 416, 10.1136/bmj.302.6773.416
Bagley, 1985 May, Ann Intern Med, 102, 719, 10.7326/0003-4819-102-5-719
Mollman, 1990 Jan 11, N Engl J Med, 322, 126, 10.1056/NEJM199001113220210
Lyass, 1998 Jan, Anticancer Drugs, 9, 100, 10.1097/00001813-199801000-00013
Thompson, 1984 Oct 1, Cancer, 54, 1269, 10.1002/1097-0142(19841001)54:7<1269::AID-CNCR2820540707>3.0.CO;2-9
Cavaletti, 1992, Acta Neuropathol, 84, 364, 10.1007/BF00227662
Von Hoff, 1979 Sep-Oct, Cancer Treat Rep, 63, 1527
Schlaeffer, 1983 Dec, Drug Intell Clin Pharm, 17, 899, 10.1177/106002808301701207
Altundag, 2001 May, Ann Pharmacother, 35, 641, 10.1345/aph.10180
Hashimi, 1984, Oncology, 41, 174, 10.1159/000225817
Fassio, 1986, Oncology, 43, 219, 10.1159/000226369
Menard, 1991 Jan, J Clin Oncol, 9, 192, 10.1200/JCO.1991.9.1.192
Von Hoff, 1976 Jan 10, Lancet, 1, 90, 10.1016/S0140-6736(76)90183-5
2005, Circulation, 112, IV1 203
Kris, 2006 Jun 20, J Clin Oncol, 24, 2932, 10.1200/JCO.2006.06.9591
De Mulder, 1990 Dec 1, Ann Intern Med, 113, 834, 10.7326/0003-4819-113-11-834
Marty, 1990 Mar 22, N Engl J Med, 322, 816, 10.1056/NEJM199003223221205
Hainsworth, 1991 May, J Clin Oncol, 9, 721, 10.1200/JCO.1991.9.5.721
Smith, 1991 Aug 24, Lancet, 338, 487, 10.1016/0140-6736(91)90555-4
Al-Sarraf, 1982 Jan, Cancer Treat Rep, 66, 31
Legha, 1985 Oct, J Clin Oncol, 3, 1373, 10.1200/JCO.1985.3.10.1373
Vogl, 1980 Jan 1, Cancer, 45, 11, 10.1002/1097-0142(19800101)45:1<11::AID-CNCR2820450104>3.0.CO;2-E
Pfeifle, 1985 Feb, J Clin Oncol, 3, 237, 10.1200/JCO.1985.3.2.237
Hirosawa, 1989, Cancer Chemother Pharmacol, 23, 255, 10.1007/BF00451652
Markman, 1991, J Cancer Res Clin Oncol, 117, 151, 10.1007/BF01613139
Howell, 1982 Dec, Ann Intern Med, 97, 845, 10.7326/0003-4819-97-6-845
Markman, 1985 Sep, Eur J Cancer Clin Oncol, 21, 1015, 10.1016/0277-5379(85)90285-8
Markman, 1985 Nov 15, Cancer, 56, 2364, 10.1002/1097-0142(19851115)56:10<2364::AID-CNCR2820561003>3.0.CO;2-4
Nagai, 1995, Cancer Chemother Pharmacol, 36, 404, 10.1007/BF00686189
Markman, 1986 Oct, Am J Clin Oncol, 9, 440, 10.1097/00000421-198610000-00016
Coiffier, 2008 Jun 1, J Clin Oncol, 26, 2767, 10.1200/JCO.2007.15.0177
Schiffer, 2001 Mar 1, J Clin Oncol, 19, 1519, 10.1200/JCO.2001.19.5.1519
Rizzo, 2008 Jan 1, Blood, 111, 25, 10.1182/blood-2007-08-109488
Smith, 2006 Jul 1, J Clin Oncol, 24, 3187, 10.1200/JCO.2006.06.4451
Hartmann, 1997 Jun 19, N Engl J Med, 336, 1776, 10.1056/NEJM199706193362502
Albers, 2007, Cochrane Database Syst Rev, &NA;, CD005228
Fisher, 2004 Dec, Pediatr Blood Cancer, 43, 780, 10.1002/pbc.20132
Sastry, 2005 Jul-Aug, Pediatr Hematol Oncol, 22, 441, 10.1080/08880010590964381
Ekborn, 2004 Sep, Laryngoscope, 114, 1660, 10.1097/00005537-200409000-00030
Qazi, 1988 Nov 16, J Natl Cancer Inst, 80, 1486, 10.1093/jnci/80.18.1486
DeGregorio, 1989, Cancer Chemother Pharmacol, 23, 276, 10.1007/BF00292403
Nisar, 2002 Jul, Ren Fail, 24, 529, 10.1081/JDI-120006780
Schweitzer, 1986 Sep, Laryngoscope, 96, 948, 10.1288/00005537-198609000-00005
Umeki, 1988 Jan, Am J Med Sci, 295, 6, 10.1097/00000441-198801000-00003
Gandhi, 2005 Dec 1, Cancer, 104, 2477, 10.1002/cncr.21442
Muller, 2003 Dec, Onkologie, 26, 539
Huertas Fernandez, 2006 Nov, Clin Transl Oncol, 8, 821, 10.1007/s12094-006-0138-1
Schulmeister, 2006 May, Oncologist, 11, 463, 10.1634/theoncologist.11-5-463
Voeffray, 2006 Dec, Qual Saf Health Care, 15, 418, 10.1136/qshc.2005.016808
